A detailed history of Net Worth Advisory Group transactions in Insulet Corp stock. As of the latest transaction made, Net Worth Advisory Group holds 875 shares of PODD stock, worth $291,112. This represents 0.05% of its overall portfolio holdings.

Number of Shares
875
Previous 871 0.46%
Holding current value
$291,112
Previous $269 Million 7.58%
% of portfolio
0.05%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 13, 2026

BUY
$305.98 - $336.84 $1,223 - $1,347
4 Added 0.46%
875 $249 Million
Q3 2025

Oct 14, 2025

BUY
$277.3 - $352.82 $241,528 - $307,306
871 New
871 $269 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Net Worth Advisory Group Portfolio

Follow Net Worth Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Net Worth Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Net Worth Advisory Group with notifications on news.